KPTI Historical PE Ratio image   This KPTI PE ratio history page last updated 11/7/2022
KPTI Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/3/2022
4.54-0.45-1.80NA
Q2 2022
8/4/2022
4.53-0.62-2.48NA
Q1 2022
5/5/2022
6.74-0.53-2.12NA
Q4 2021
2/8/2022
8.190.461.844.5
Q3 2021
11/3/2021
7.94-0.69-2.76NA
Q2 2021
8/5/2021
5.93-0.71-2.84NA
Q1 2021
5/3/2021
9.44-0.77-3.08NA
Q4 2020
2/11/2021
15.35-0.59-2.36NA
Q3 2020
11/2/2020
14.50-0.73-2.92NA
Q2 2020
8/4/2020
15.76-0.63-2.52NA
Q1 2020
5/5/2020
19.63-0.78-3.12NA
Q4 2019
2/13/2020
16.07-0.76-3.04NA
Q3 2019
11/4/2019
13.32-0.67-2.68NA
Q2 2019
8/6/2019
8.30-0.71-2.84NA
Q1 2019
5/9/2019
4.63-1.09-4.36NA
Q4 2018
2/28/2019
4.13-0.96-3.84NA
Q3 2018
11/8/2018
11.55-0.79-3.16NA
Q2 2018
8/7/2018
18.38-0.60-2.40NA
Q1 2018
5/10/2018
17.01-0.78-3.12NA
Q4 2017
3/15/2018
16.16-0.80-3.20NA
Q3 2017
11/2/2017
10.49-0.65-2.60NA
Q2 2017
8/8/2017
8.85-0.64-2.56NA
Q1 2017
5/4/2017
8.67-0.71-2.84NA
Q4 2016
3/16/2017
10.51-0.65-2.60NA
Q3 2016
11/7/2016
6.92-0.69-2.76NA
Q2 2016
8/4/2016
6.80-0.84-3.36NA
Q1 2016
5/9/2016
8.26-0.75-3.00NA
Q4 2015
3/14/2016
8.87-0.81-3.24NA
Q3 2015
11/9/2015
15.70-0.85-3.40NA
Q2 2015
8/10/2015
13.44-0.92-3.68NA
Q1 2015
5/11/2015
29.45-0.74-2.96NA
Q4 2014
3/16/2015
31.56-0.79-3.16NA
Q3 2014
11/10/2014
42.68-0.61-2.44NA
Q2 2014
8/7/2014
35.48-0.55-2.20NA
Q1 2014
5/7/2014
26.36-0.46-1.84NA
KPTI PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/3/2022
4.54-0.45-1.14NA
Q2 2022
8/4/2022
4.53-0.62-1.38NA
Q1 2022
5/5/2022
6.74-0.53-1.47NA
Q4 2021
2/8/2022
8.190.46-1.71NA
Q3 2021
11/3/2021
7.94-0.69-2.76NA
Q2 2021
8/5/2021
5.93-0.71-2.80NA
Q1 2021
5/3/2021
9.44-0.77-2.72NA
Q4 2020
2/11/2021
15.35-0.59-2.73NA
Q3 2020
11/2/2020
14.50-0.73-2.90NA
Q2 2020
8/4/2020
15.76-0.63-2.84NA
Q1 2020
5/5/2020
19.63-0.78-2.92NA
Q4 2019
2/13/2020
16.07-0.76-3.23NA
Q3 2019
11/4/2019
13.32-0.67-3.43NA
Q2 2019
8/6/2019
8.30-0.71-3.55NA
Q1 2019
5/9/2019
4.63-1.09-3.44NA
Q4 2018
2/28/2019
4.13-0.96-3.13NA
Q3 2018
11/8/2018
11.55-0.79-2.97NA
Q2 2018
8/7/2018
18.38-0.60-2.83NA
Q1 2018
5/10/2018
17.01-0.78-2.87NA
Q4 2017
3/15/2018
16.16-0.80-2.80NA
Q3 2017
11/2/2017
10.49-0.65-2.65NA
Q2 2017
8/8/2017
8.85-0.64-2.69NA
Q1 2017
5/4/2017
8.67-0.71-2.89NA
Q4 2016
3/16/2017
10.51-0.65-2.93NA
Q3 2016
11/7/2016
6.92-0.69-3.09NA
Q2 2016
8/4/2016
6.80-0.84-3.25NA
Q1 2016
5/9/2016
8.26-0.75-3.33NA
Q4 2015
3/14/2016
8.87-0.81-3.32NA
Q3 2015
11/9/2015
15.70-0.85-3.30NA
Q2 2015
8/10/2015
13.44-0.92-3.06NA
Q1 2015
5/11/2015
29.45-0.74-2.69NA
Q4 2014
3/16/2015
31.56-0.79-2.41NA
Q3 2014
11/10/2014
42.68-0.61NANA
Q2 2014
8/7/2014
35.48-0.55NANA
Q1 2014
5/7/2014
26.36-0.46NANA
Quotes delayed 20 minutes

Email EnvelopeFree KPTI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Karyopharm Therapeutics (KPTI) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

KRBP PE Ratio History
KRMD PE Ratio History
KRON PE Ratio History
KROS PE Ratio History
KRTX PE Ratio History
KRYS PE Ratio History
KTRA PE Ratio History
KTTA PE Ratio History
KURA PE Ratio History
KYMR PE Ratio History
How should the KPTI historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Karyopharm Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this KPTI Historical PE Ratio page.

What is the average historical PE for KPTI based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The KPTI historical PE ratio using the annualized quarterly earnings method works out to 4.5.

What is the average historical PE for KPTI based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The KPTI historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the KPTI Historical PE Ratio information for Karyopharm Therapeutics' stock. The average KPTI historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 4.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average KPTI historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this KPTI historical PE result, against the recent PE: when this page was posted on 11/4/2022, the most recent closing price for KPTI had been 4.74, and the most recent quarterly earnings result, annualized, was 1.84. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent KPTI PE on 11/4/2022 based on annualized quarterly EPS was 2.6. Based on KPTI's history, that recent PE is low relative to the historical average, with the recent PE 42.2% lower than the historical average PE across our data set for Karyopharm Therapeutics.

For self directed investors doing their due diligence on KPTI or any other given stock, valuation analysis for KPTI can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Karyopharm Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KPTI. Thanks for visiting, and the next time you need to research KPTI Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: EVBG Insider Buying, Institutional Holders of XOG, EWM Dividend History.

 

KPTI Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.